| 摘要 |
The present invention provides methods, kits, and pharmaceutical composition s for limiting scar or adhesion formation by administration of angiotensinogen , AI, AI analogues, and/or AI fragments and analogues thereof, AII analogues, AII fragments or analogues thereof, ACE inhibitors, AII AT2 type 2 receptor agonists, either alone or in combination with other compounds.
|
